Teracyte Analytics

Developer of computational models designed to predict cellular responses to various stimuli.

Health Tech & Life Sciences
Active
Seed Caesarea, Israel Founded 2020
Last updated 2026-07-26
Total raised
$1.5M
Last: Seed 2022-01
Stage
Seed
Founded
2020
Headcount
20
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences

About

TeraCyte Analytics developed a platform for high-throughput temporal analysis of live single-cells, based on proprietary array chips, an imaging system, and analytical tools. The platform enables temporal analysis of single-cells in high scale and accuracy, for applications in research, development, and manufacturing of drugs and other bio-products. TeraCyte's AI models can distinguish between various cell types, count cells, and identify cell-cell interactions. The company's technology offers analytical capabilities, facilitating the understanding and forecasting of cell reactions to new drugs or perturbations in the medical field, enabling pharmaceutical researchers and medical professionals to make informed decisions regarding drug development and treatment strategies. TeraCyte's solution can be used for discovery, development and manufacturing of cell therapies, biological and small molecule drugs.

Funding history · 1 round · $1.5M total

2021-12
Seed $1.5M
★ Israel Innovation Authority

Headcount over time

From 8 (2024-01) to 19 (2025-10) · +11 (+138%) · 5 points · source: Finder history + radar grounding
190 2024-01 2025-10

Q&A

What is Teracyte Analytics' primary business?
Teracyte Analytics develops computational models to predict cellular responses to various stimuli, utilizing a platform for high-throughput temporal analysis of live single-cells based on proprietary array chips, an imaging system, and analytical tools.
When was Teracyte Analytics founded?
Teracyte Analytics was founded in March 2020.
What is the current employee count for Teracyte Analytics?
Teracyte Analytics has 11-50 employees.
What is Teracyte Analytics' total funding to date?
Teracyte Analytics has raised a total of $1,550,000 USD.
When was Teracyte Analytics' most recent funding round?
Teracyte Analytics completed a Seed funding round in April 2023, raising $1,550,000 USD.
Who are the co-founders of Teracyte Analytics?
The co-founders of Teracyte Analytics are Yoav Nissan-Cohen (CEO) and Gal Lenz (CTO).
What sectors does Teracyte Analytics operate in?
Teracyte Analytics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, and Drugs Discovery & Development sectors.
What technologies does Teracyte Analytics utilize?
Teracyte Analytics utilizes Simulation & Imaging, Semiconductors & Electronics, Chipsets, and Artificial Intelligence technologies.

Team · 4

Yoav Nissan-Cohen
Founder · CEO & Co-Founder
Gal Lenz
Founder · CTO & Co-Founder
Member of the Board
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Simulation & ImagingSemiconductors & ElectronicsChipsetsArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B

Tags

drug-developmentpredictive-analyticspharmaceuticalscellsbiotechnologycell-therapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteteracyte.ai
LinkedInlinkedin.com/company/80273523
Facebookfacebook.com/profile.php?id=100083173158462

Identifiers & details

Legal nameTERACYTE ANALYTICS LTD
Founded2020-3
Employees (exact)20

Radar intelligence

Patents

EPO4

Web history (Wayback)

Domainteracyte.ai

Certificate / subdomain footprint

Subdomains3

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516174778
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2020-03-10
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens1
Registry events2 — shares_capital (1), charge (1)
Registered addressגולדה מאיר 3 נס ציונה

Recent registry events

DateEvent
2026-06-16הקצאת מניות
2025-09-10רישום שעבוד